Our multidisciplinary team of experts is committed to providing the highest level of diagnostic accuracy and patient care. This is done using the latest neurophysiological tests, MRI scans, nerve and muscle techniques. Our scientific interests range from basic research, such as novel drug development or studies using disease models of ALS, to clinical studies (e.g clinical trials, MRI studies). We are part of the Institute of Experimental Neurology (INSPE), which is dedicated to translational research in the neuroscience field, and we collaborate with several laboratories in Italy and Europe.
Amylyx Pharmaceuticals Inc is conducting a phase 3 trial to determine the safety and efficacy of their compound ‘AMX0035’ for the treatment of ALS.